What is EW's P/E ratio?

EDWARDS LIFESCIENCES CORP (EW) currently trades at a P/E ratio of 49.80.

EDWARDS LIFESCIENCES CORP reports a Return on Equity (ROE) of -8,160.23%.

What is EW's dividend yield?

EDWARDS LIFESCIENCES CORP offers a dividend yield of 0.00%.

What is EW's Quality Score?

Our AI rates EW's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy EW?

Our AI Timing Score for EW is 55 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does EW belong to?

EDWARDS LIFESCIENCES CORP is classified under the Healthcare >> Medical Devices sector on the NYSE exchange

EW (NYSE) Stock Analysis | EDWARDS LIFESCIENCES CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

EW AI Analysis Summary

Our AI summary for EW: EDWARDS LIFESCIENCES CORP (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 49.80, ROE of -8,160.23%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 55/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

EW

EDWARDS LIFESCIENCES CORP

US:NYSE STOCK Healthcare >> Medical Devices News 95

USD 86.07

-0.85 (-0.98%) Day Change

Watchlist Portfolio Compare Chart

49.80

P/E

-10.42

D/E

-8,160.2%

ROE

866.1%

ROA

0.00%

Div Yield

1.21

PEG

Data partially updated

EDWARDS LIFESCIENCES CORP
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 86.07 Price -0.85 (-0.98%) Day Change	NEWS SCORE: 95

EW, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is good , ...

Quality Factors

55%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	95
Magic Formula Rank by ROA	1929
Magic Formula Rank by ROE	1929
Magic Formula Rank by ROIC	1991
Price	86.07
PBV / Sector	-4,064.16 / -101.57
Earning Per Share	1.73

PE / Sector	49.80 / 31.23
PEG or PE/Growth / Sector	1.21 / 0.40
Average 1M Daily Value	391.93 M GREAT
Average 1W Daily Value	307.86 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

70%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	15.43 / 20.50 GOOD
NPM Average (%) / Sector	32.30 / -15.37 GREAT
NPM Change Average (%) / Sector	30.37 / 7.34 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	866.06 / 39.11 GREAT
ROA Average (%) / Sector	187.84 / 5.58 GREAT
ROA Change Average (%) / Sector	2,742.51 / 104.50 GOOD
ROE (%) / Sector	-8,160.23 / -166.42
ROE Average (%) / Sector	-1,612.16 / -16.93
ROE Change Average (%) / Sector	-19,669.53 / -500.08
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 07:59:48
Symbol	EW
Name	EDWARDS LIFESCIENCES CORP
Sector	Healthcare >> Medical Devices
Market	NYSE
Listed Shares	575.80 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	50,048.54 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: One Edwards Way, Irvine, CA, United States, 92614

Phone: 949 250 2500

Website: https://www.edwards.com

Employees: 16,000

Sector: Healthcare >> Medical Devices

Description: Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.